Inhalable CAR-T cell-derived exosomes as paclitaxel carriers for treating lung cancer

被引:0
作者
Wei Zheng
Tianchuan Zhu
Lantian Tang
Zhijian Li
Guanmin Jiang
Xi Huang
机构
[1] The Fifth Affiliated Hospital of Sun Yat-Sen University,Center for Infection and Immunity, Guangdong Provincial Key Laboratory of Biomedical Imaging
[2] The Fifth Affiliated Hospital of Sun Yat-Sen University,Department of Clinical Laboratory
[3] Foshan Fourth People’s Hospital,undefined
来源
Journal of Translational Medicine | / 21卷
关键词
Lung cancer; CAR-T; Exosomes; Paclitaxel; Inhalation; Targeted delivery;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 458 条
[1]  
Siegel RL(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
[2]  
Miller KD(2018)The biology and management of non-small cell lung cancer Nature 553 446-454
[3]  
Fuchs HE(2018)Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Ann Oncol 29 iv192-iv237
[4]  
Jemal A(1990)Hypersensitivity reactions from taxol J Clin Oncol 8 1263-1268
[5]  
Herbst RS(1979)Promotion of microtubule assembly in vitro by taxol Nature 277 665-667
[6]  
Morgensztern D(2020)Ultrasound-mediated delivery of paclitaxel for glioma: a comparative study of distribution, toxicity, and efficacy of albumin-bound versus cremophor formulations Clin Cancer Res 26 477-486
[7]  
Boshoff C(2020)Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer Cancer Lett 495 76-88
[8]  
Planchard D(2020)The biology, function, and biomedical applications of exosomes Science 367 56-1038
[9]  
Popat S(2022)Exosomes as a new frontier of cancer liquid biopsy Mol Cancer 21 4355-374
[10]  
Kerr K(2019)CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity Nat Commun 10 1026-161